Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19

OBJECTIVE: This was a post hoc analysis of the Edaravone Phase III Study MCI186-19 (‘Study 19’) to examine the utility of clinical staging systems as end points in clinical trials in amyotrophic lateral sclerosis (ALS). METHODS: Amyotrophic Lateral Sclerosis Functional Rating Scale—Revised item scor...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Chalabi, Ammar, Chiò, Adriano, Merrill, Charlotte, Oster, Gerry, Bornheimer, Rebecca, Agnese, Wendy, Apple, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Neuromuscular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841496/
https://www.ncbi.nlm.nih.gov/pubmed/33109706
http://dx.doi.org/10.1136/jnnp-2020-323271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841496/
https://www.ncbi.nlm.nih.gov/pubmed/33109706
http://dx.doi.org/10.1136/jnnp-2020-323271

Ejemplares similares